Production (Stage)
Zimmer Biomet Holdings, Inc.
ZBH
$92.64
$0.971.06%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.70B | 7.68B | 7.60B | 7.52B | 7.45B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.70B | 7.68B | 7.60B | 7.52B | 7.45B |
| Cost of Revenue | 2.22B | 2.18B | 2.13B | 2.11B | 2.09B |
| Gross Profit | 5.48B | 5.50B | 5.47B | 5.41B | 5.37B |
| SG&A Expenses | 2.90B | 2.88B | 2.86B | 2.82B | 2.82B |
| Depreciation & Amortization | 600.80M | 591.90M | 579.20M | 576.00M | 570.20M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.16B | 6.09B | 6.00B | 5.96B | 5.93B |
| Operating Income | 1.54B | 1.59B | 1.59B | 1.56B | 1.52B |
| Income Before Tax | 1.05B | 1.04B | 1.03B | 1.02B | 995.60M |
| Income Tax Expenses | 135.60M | 131.40M | -52.70M | 22.60M | 30.40M |
| Earnings from Continuing Operations | 915.20 | 905.40 | 1.08K | 998.50 | 965.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.80M | -1.60M | -1.40M | -1.40M | -1.30M |
| Net Income | 913.40M | 903.80M | 1.08B | 997.10M | 963.90M |
| EBIT | 1.54B | 1.59B | 1.59B | 1.56B | 1.52B |
| EBITDA | 2.55B | 2.59B | 2.56B | 2.53B | 2.48B |
| EPS Basic | 4.53 | 4.45 | 5.27 | 4.82 | 4.64 |
| Normalized Basic EPS | 4.02 | 4.19 | 4.15 | 4.04 | 3.89 |
| EPS Diluted | 4.51 | 4.44 | 5.26 | 4.80 | 4.62 |
| Normalized Diluted EPS | 4.01 | 4.17 | 4.13 | 4.03 | 3.87 |
| Average Basic Shares Outstanding | 806.00M | 812.30M | 821.10M | 827.70M | 830.60M |
| Average Diluted Shares Outstanding | 809.00M | 815.50M | 824.20M | 831.20M | 834.70M |
| Dividend Per Share | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Payout Ratio | 21.28% | 21.69% | 18.29% | 19.97% | 20.75% |